Trials / Terminated
TerminatedNCT00816829
Effect of Fenofibrate on Sleep Apnea Syndrome
A 1-month, Randomized, Double-blind, Placebo-controlled Study of Fenofibrate 145 mg Tablet in Patients With Sleep Apnea Syndrome
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Solvay Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Objectives: to investigate for the potential effect of fenofibrate on symptoms and biological changes associated with sleep apnea syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Fenofibrate-matching placebo tablet |
| DRUG | Fenofibrate | 145 mg NanoCrystal tablet |
Timeline
- Start date
- 2005-09-01
- Primary completion
- 2008-01-01
- Completion
- 2008-01-01
- First posted
- 2009-01-05
- Last updated
- 2009-07-22
- Results posted
- 2009-07-07
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00816829. Inclusion in this directory is not an endorsement.